TriSalus Life Sciences Files Q1 2025 10-Q

Ticker: TLSIW · Form: 10-Q · Filed: May 15, 2025 · CIK: 1826667

Trisalus Life Sciences, Inc. 10-Q Filing Summary
FieldDetail
CompanyTrisalus Life Sciences, Inc. (TLSIW)
Form Type10-Q
Filed DateMay 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, capital-structure

TL;DR

TriSalus Q1 2025 10-Q is in. Financials updated, check stock and capital changes.

AI Summary

TriSalus Life Sciences, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including common stock, preferred stock, and additional paid-in capital as of December 31, 2024, and March 31, 2025. It also reports on warrants and retained earnings for the same periods.

Why It Matters

This filing provides investors with an update on TriSalus Life Sciences' financial position and capital structure as of the end of the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.

Key Numbers

  • 20250331 — Period End Date (The 10-Q covers the period ending March 31, 2025.)
  • 20250515 — Filing Date (The 10-Q was filed on May 15, 2025.)

Key Players & Entities

  • TriSalus Life Sciences, Inc. (company) — Filer of the 10-Q
  • MedTech Acquisition Corp (company) — Former name of TriSalus Life Sciences, Inc.
  • 0001826667-25-000051 (filing_id) — Accession Number for the 10-Q filing

FAQ

What were the key financial statement line items reported for the quarter ending March 31, 2025?

The filing reports on common stock, preferred stock, additional paid-in capital, and retained earnings for the period ending March 31, 2025, comparing them to December 31, 2024.

What is the company's primary business as indicated by its SIC code?

The company's SIC code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.

When did TriSalus Life Sciences, Inc. change its name from MedTech Acquisition Corp?

The date of the name change from MedTech Acquisition Corp to TriSalus Life Sciences, Inc. was September 30, 2020.

What is the company's fiscal year end?

The company's fiscal year ends on December 31.

What is the business address and phone number listed for TriSalus Life Sciences?

The business address is 6272 West 91st Avenue, Westminster, CO 80031, and the business phone number is 415 336 8917.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding TriSalus Life Sciences, Inc. (TLSIW).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.